# FLULAVAL 2025/2026

NDC: 19515-904
Generic name: influenza virus vaccine
Labeler / Manufacturer: ID Biomedical Corporation of Quebec
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAMUSCULAR
Marketing started: 20250701
Marketing ended: 20260630
FDA application: BLA125163

## Active ingredients

- INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED): 15 ug/.5mL
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED): 15 ug/.5mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED): 15 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"19515-904"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=19515-904